Covered recipient · General Payments record
GRACE M SALINAS GARCIA
Allopathic & Osteopathic Physicians Psychiatry & Neurology Child & Adolescent Psychiatry
General Payments · PY2018–2024
$2,130.88
- Reported across 115 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $371.25 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $173.16 | 7 |
| Tris Pharma Inc | $79.56 | 3 |
| Corium, Inc. | $45.77 | 3 |
| Supernus Pharmaceuticals, Inc. | $34.02 | 2 |
| Alkermes, Inc. | $23.49 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $15.25 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.67 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106006930 | CMS |
| ABBVIE INC. | $8.96 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106006932 | CMS |
| ABBVIE INC. | $32.73 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106006934 | CMS |
| ABBVIE INC. | $33.38 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106006936 | CMS |
| ABBVIE INC. | $29.92 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106006938 | CMS |
| ABBVIE INC. | $30.50 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106006940 | CMS |
| ABBVIE INC. | $12.00 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106006942 | CMS |
| Alkermes, Inc. | $23.49 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120589036 | CMS |
| Corium, LLC | $29.06 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100076337 | CMS |
| Corium, LLC | $14.82 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100113312 | CMS |
| Corium, LLC | $1.89 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100136621 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $15.25 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146760154 | CMS |
| Supernus Pharmaceuticals, Inc. | $14.40 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147784004 | CMS |
| Supernus Pharmaceuticals, Inc. | $19.62 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147784006 | CMS |
| Tris Pharma Inc | $23.46 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147233883 | CMS |
| Tris Pharma Inc | $28.05 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147233885 | CMS |
| Tris Pharma Inc | $28.05 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147233887 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.